207 related articles for article (PubMed ID: 22452654)
1. Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program.
Young C; Chawla A; Berardi V; Padbury J; Skowron G; Krause PJ;
Transfusion; 2012 Jul; 52(7):1523-9. PubMed ID: 22452654
[TBL] [Abstract][Full Text] [Related]
2. Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area.
Johnson ST; Cable RG; Leiby DA
Transfusion; 2012 Jul; 52(7):1509-16. PubMed ID: 21910741
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of Babesia microti antibody and nucleic acid blood donation screening using results from prospective investigational studies.
Bish EK; Moritz ED; El-Amine H; Bish DR; Stramer SL
Transfusion; 2015 Sep; 55(9):2256-71. PubMed ID: 25995054
[TBL] [Abstract][Full Text] [Related]
4. A fatal case of transfusion-transmitted babesiosis in the State of Delaware.
Zhao Y; Love KR; Hall SW; Beardell FV
Transfusion; 2009 Dec; 49(12):2583-7. PubMed ID: 19906041
[TBL] [Abstract][Full Text] [Related]
5. Screening for Babesia microti in the U.S. Blood Supply.
Moritz ED; Winton CS; Tonnetti L; Townsend RL; Berardi VP; Hewins ME; Weeks KE; Dodd RY; Stramer SL
N Engl J Med; 2016 Dec; 375(23):2236-2245. PubMed ID: 27959685
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of transfusion-transmitted Babesia microti, American Red Cross 2010-2017.
Tonnetti L; Townsend RL; Dodd RY; Stramer SL
Transfusion; 2019 Sep; 59(9):2908-2912. PubMed ID: 31250463
[TBL] [Abstract][Full Text] [Related]
7. The impact of Babesia microti blood donation screening.
Tonnetti L; Townsend RL; Deisting BM; Haynes JM; Dodd RY; Stramer SL
Transfusion; 2019 Feb; 59(2):593-600. PubMed ID: 30499595
[TBL] [Abstract][Full Text] [Related]
8. Transfusion-transmitted Babesia microti identified through hemovigilance.
Tonnetti L; Eder AF; Dy B; Kennedy J; Pisciotto P; Benjamin RJ; Leiby DA
Transfusion; 2009 Dec; 49(12):2557-63. PubMed ID: 19624607
[TBL] [Abstract][Full Text] [Related]
9. Babesia microti seroprevalence in Minnesota blood donors.
Tonnetti L; Thorp AM; Deisting B; Bachowski G; Johnson ST; Wey AR; Hodges JS; Leiby DA; Mair D
Transfusion; 2013 Aug; 53(8):1698-705. PubMed ID: 23145838
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-Transmitted Babesia microti.
Fang DC; McCullough J
Transfus Med Rev; 2016 Jul; 30(3):132-8. PubMed ID: 27260107
[TBL] [Abstract][Full Text] [Related]
11. Babesia microti real-time polymerase chain reaction testing of Connecticut blood donors: potential implications for screening algorithms.
Johnson ST; Van Tassell ER; Tonnetti L; Cable RG; Berardi VP; Leiby DA
Transfusion; 2013 Nov; 53(11):2644-9. PubMed ID: 23445322
[TBL] [Abstract][Full Text] [Related]
12. Transfusion-transmitted babesiosis: is it time to screen the blood supply?
Levin AE; Krause PJ
Curr Opin Hematol; 2016 Nov; 23(6):573-580. PubMed ID: 27537475
[TBL] [Abstract][Full Text] [Related]
13. Transfusion-transmitted babesiosis: one state's experience.
Klevens RM; Cumming MA; Caten E; Stramer SL; Townsend RL; Tonnetti L; Rios J; Young CT; Soliva S; DeMaria A
Transfusion; 2018 Nov; 58(11):2611-2616. PubMed ID: 30260481
[TBL] [Abstract][Full Text] [Related]
14. Transfusion-transmitted babesiosis in Rhode Island.
Asad S; Sweeney J; Mermel LA
Transfusion; 2009 Dec; 49(12):2564-73. PubMed ID: 19761547
[TBL] [Abstract][Full Text] [Related]
15. The third described case of transfusion-transmitted Babesia duncani.
Bloch EM; Herwaldt BL; Leiby DA; Shaieb A; Herron RM; Chervenak M; Reed W; Hunter R; Ryals R; Hagar W; Xayavong MV; Slemenda SB; Pieniazek NJ; Wilkins PP; Kjemtrup AM
Transfusion; 2012 Jul; 52(7):1517-22. PubMed ID: 22168221
[TBL] [Abstract][Full Text] [Related]
16. Costs, consequences, and cost-effectiveness of strategies for Babesia microti donor screening of the US blood supply.
Goodell AJ; Bloch EM; Krause PJ; Custer B
Transfusion; 2014 Sep; 54(9):2245-57. PubMed ID: 25109338
[TBL] [Abstract][Full Text] [Related]
17. A novel quantitative PCR detects Babesia infection in patients not identified by currently available non-nucleic acid amplification tests.
Akoolo L; Schlachter S; Khan R; Alter L; Rojtman AD; Gedroic K; Bhanot P; Parveen N
BMC Microbiol; 2017 Jan; 17(1):16. PubMed ID: 28088177
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Babesia microti in blood donors from Babesia-endemic areas of the northeastern United States: 2000 through 2007.
Johnson ST; Cable RG; Tonnetti L; Spencer B; Rios J; Leiby DA
Transfusion; 2009 Dec; 49(12):2574-82. PubMed ID: 19821951
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States.
Simon MS; Leff JA; Pandya A; Cushing M; Shaz BH; Calfee DP; Schackman BR; Mushlin AI
Transfusion; 2014 Mar; 54(3 Pt 2):889-99. PubMed ID: 24252132
[TBL] [Abstract][Full Text] [Related]
20. Transfusion-associated babesiosis in the United States: a description of cases.
Herwaldt BL; Linden JV; Bosserman E; Young C; Olkowska D; Wilson M
Ann Intern Med; 2011 Oct; 155(8):509-19. PubMed ID: 21893613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
